Saleeby, Eli, Kenneth Bielinski, Alison Fitzgerald, Jennifer Siegel, and Sherrif Ibrahim. “A Prospective, Multi-Center Clinical Utility Study Demonstrates That the 40-Gene Expression Profile (40-GEP) Test Impacts Clinical Management for Medicare-Eligible Patients With High-Risk Cutaneous Squamous Cell Carcinoma (cSCC)”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): 482–496. Accessed July 3, 2024. https://jofskin.org/33014/index.php/skin/article/view/1788.